Featured Articles

71. Genomic Medicine And The Tools To Realize Its Potential 1/12/2022

    New technologies and collaborations driving the democratization of RNA therapeutics are creating an explosion of opportunity for companies pursuing the development of these transformative medicines.

72. Key Insights Into Overcoming mRNA Process Challenges 9/8/2021

    Realizing the potential of mRNA requires focus on key areas and strategies that could help alleviate the bottlenecks in this growing market segment.

73. mRNA Manufacturing Workflow 6/2/2021

    Therapies based on messenger RNA, such as mRNA vaccines, have revolutionary potential. Learn more about key objectives, considerations, and strategies in mRNA manufacturing.

74. Automating Cell Therapy Manufacturing For GMP Compliance And Consistency 11/1/2019

     

    Exploring the use of automation in cell therapy and advanced therapeutic medicinal product manufacturing to improve safety, quality, and compliance is a key factor in advancing patient care.

     

75. GMP Cell Therapy Manufacturing: How And When To Get Started 5/2/2019

    As hospitals and translational facilities explore implementation, they concurrently evaluate whether or not to manufacture the therapies onsite. Here is a guideline of how and when to get started.

76. Cell Therapy Manufacturing: The Supply Chain Challenge 4/1/2019

    Overcoming the challenges of manufacturing and administering a complex product to any patient is critical for delivering cell therapies. Two industry experts detail strategies to meet supply chain challenges.

77. Add mRNA Capacity — Flexibly

    Learn about a platform that addresses five critical pain points to help mRNA manufacturers flexibly scale while improving the digital maturity of their sites.

78. Oligonucleotide Manufacturing: Take Control Of Your Process

    What do you need to know before you take your process in-house? A team of experts on nucleic acids therapeutics outlined five key things for you to consider as you make the change.